1Paine, MF, Wagner DA, Keith, BS, et al. Cytochrome P4503A4 and P-glycoprotein mediate the interaction between and oral erythomycin breath test and refampin [J]. Clinical Pharmacology & Therepeutics,2002,72(5) :524.
2Lauterburg BH, Grattagliano I, Gmur R, et al. Noninvasive assessment of the effect of xenobiotics on mitochondrial function in human beings: studies with acetylsalicylic acid and ethanol with the use of the carbon 13-labeled ketoisocaproate breath test [
3rmuzzi. A, anaelli, et al. Review article: breath testing for humber liver function assessment [J]. Blackwell Science Ltd,2002,16(2):1977.
4Renner E, Wietholtz H, Huguenin P,et al. Caffeine: a model compound for measuring liver function [J]. Hepatology,1984,4:38.
5Giannini E, Fasoli A, Chiabonello B, et al.13C-aminopyrine breath test to eavalute severity of disease in patients with chronic hepatitis C virus infection [J]. Blackwell Science Ltd, 16(4) :715.
6Matsumtoto K, Suehiro M, Kawabe T, et al. [13C] methacetin breath test for evaluation of liver damage [J]. Dig Dis Sci, 1987,32(4) :344.
7Klatt S, Taut C, Mayer D, et al. Evaluation of the 13C-methacetin breath test for quantitatine liver function testing [J]. Z Gastroentero, 1997,35(8):609.
8Amaud MJ, Thelin-Doemer A, Ravussin E, et al. Study of the demethylation of (1,3,7-methyl 13C) caffeine in man using respiratory exchange measurements [J]. Biomed Mass Spectrom, 1980,7:521.
9Schmidt LE, Kristensen OA, Stentoft K, et al. Early postoperative erythromycin breath test correlates with hepatic cytochrome P4503A activity in liver transplant recipients [J]. Clin Pharmacol Ther,2001,70:446.
10The French METAVIR Cooperative Study Group. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C [J]. Hepatology, 1994,20:15.
2Braden B,Lembcke B,Kuker W,et al.^13C-breath tests:current state of the art and future directions.Dig Liver Dis,2007,39:795-805.
3Winiarski M,Bielanski W,Plonka M,et al.The usefulness of calpsulated ^13C-urea breath test in diagnosis of Helicobacter pylori infection in patients with upper gastrointestinal bleeding.J Clin Gastroenterol,2003,37:34-38.
4Toporowska-Kowalska E,Wasowska-Królikowska K,Szadkewska A,et al.Helicobacter pylori infection and its metabolic consequences in children and adolescents with type 1 diabetes mellitus.Med Wieku Rozwoj,2007,11:103-108.
5Sanaka M,Yamamoto T,Nakayama S,et al.Reliability of the time to maximal[^13CO_2]excretion and the half-[^13CO_2]excretion time as a gastric emptying parameter:assessments using the Wagner-Nelson method.J Smooth Muscle Res,2007,43:201-209.
6Chey WD,Shapiro B,Zawadski A,et al.Gastric emptying characteristics of a novel ^13C-octanoate-labeled muffin meal.J Clin Gastroenterol,2001,32:394-399.
7Matsumoto M,Yoshimura R,Akiho H,et al.Gastric emptying in diabetic patients by the ^13C-octanoic acid breath test:role of insulin in gastric motility.J Gastroenterol,2007,42:469-474.
8Dominguez-Mu(n)oz JE,Iglesias-García J,Vilari(n)o-Insua M,et al.^13C-mixed triglyceride breath test to assess oral enzyme substitution therapy in patients with chronic pancreatitis.Clin Gastroenterol Hepatol,2007,5:484-488.
9Uchida M,Mogami O.Usefulness of breath test for evaluating pancreatic exocrine function using N-benzoyl-L-tyrosyl-1-13 C-L-alanine sodium in non-invasive and conscious rats.Biol Pharm Bull,2008,31:785-788.
10Ishii Y,Kohno T,Ito A,et al.Evaluation of pancreatic exocrine secretion using ^13C-dipeptide (benzoyl-L-tyrosyl-[1-^13C]alanine)breath test:focusing on pancreatoduodenectomy cases.Pancreas.2007,35:313-319.
